Lessee, Operating Lease, Liability, to be Paid, Year One of ENZO BIOCHEM INC from 31 Jul 2020 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
ENZO BIOCHEM INC quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Jul 2020 to 30 Apr 2025.
  • ENZO BIOCHEM INC Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Apr 2025 was $989,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

ENZO BIOCHEM INC Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $989,000 +$93,000 +10% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 $906,000 +$10,000 +1.1% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q2
Q3 2024 $731,000 -$132,000 -15% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 $978,000 -$178,000 -15% 31 Jul 2024 10-K 29 Oct 2024 2024 FY
Q1 2024 $896,000 -$241,000 -21% 30 Apr 2024 10-Q 13 Jun 2024 2024 Q3
Q4 2023 $896,000 -$1,184,000 -57% 31 Jan 2024 10-Q 13 Mar 2024 2024 Q2
Q3 2023 $863,000 -$2,255,000 -72% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q1
Q2 2023 $1,156,000 -$2,973,000 -72% 31 Jul 2023 10-K 03 Nov 2023 2023 FY
Q1 2023 $1,137,000 +$73,000 +6.9% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 $2,080,000 -$11,000 -0.53% 31 Jan 2023 10-Q 20 Mar 2023 2023 Q2
Q3 2022 $3,118,000 -$76,000 -2.4% 31 Oct 2022 10-Q 12 Dec 2022 2023 Q1
Q2 2022 $4,129,000 -$197,000 -4.6% 31 Jul 2022 10-K 14 Oct 2022 2022 FY
Q1 2022 $1,064,000 30 Apr 2022 10-Q 09 Jun 2022 2022 Q3
Q4 2021 $2,091,000 -$345,000 -14% 31 Jan 2022 10-Q 14 Mar 2022 2022 Q2
Q3 2021 $3,194,000 31 Oct 2021 10-Q 15 Dec 2021 2022 Q1
Q2 2021 $4,326,000 +$3,145,000 +266% 31 Jul 2021 10-K 12 Oct 2021 2021 FY
Q4 2020 $2,436,000 31 Jan 2021 10-Q 16 Mar 2021 2021 Q2
Q2 2020 $1,181,000 31 Jul 2020 10-Q 11 Jun 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.